|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-7-5
|
|
pubmed:abstractText |
The development of vaccines and drugs to control leishmaniasis is urgently needed. The presence of a leishmania transferrin receptor on the parasite suggests that an adequate supply of iron is needed for the life cycle of leishmania. We have investigated the effect of iron deprivation on the growth of leishmania promastigotes in vitro using an iron chelation approach. All chelators tested reduced the rate of promastigote multiplication in a dose-dependent fashion, whereas referrated ones did not. The hydroxypyridin-4-one chelators CP94 and L1 were found to be more efficient than desferrioxamine. We suggest that iron depletion may be an effective mechanism against leishmania infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
23-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7768775-Animals,
pubmed-meshheading:7768775-DNA,
pubmed-meshheading:7768775-Deferoxamine,
pubmed-meshheading:7768775-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:7768775-Immunoblotting,
pubmed-meshheading:7768775-Iodine Radioisotopes,
pubmed-meshheading:7768775-Iron Chelating Agents,
pubmed-meshheading:7768775-Leishmania infantum,
pubmed-meshheading:7768775-Leishmania major,
pubmed-meshheading:7768775-Pyridones,
pubmed-meshheading:7768775-Transferrin
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Effect of iron chelation on the in-vitro growth of Leishmania promastigotes.
|
|
pubmed:affiliation |
Laboratory of Biochemistry, Hellenic Pasteur Institute, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
